PINK holdings
All 53 positions of Simplify Health Care ETF. as of Oct 8, 2026third-party data
These holdings are a third-party snapshot of the fund, priced at the close of Oct 8, 2026 and refreshed about once a week. It is not the fund's own file, so position changes are not tracked from it.
Positions
53
Top 10 weight
56.0%
Effective holdings
22.7
1 / sum of squared weights
In stocks
99.3%
In bonds
0.0%
Outside the US
0.0%
Asset mix
Sectors
100% of stocks classifiedCountries
Country not reported.
Holdings
as of Oct 8, 2026third-party data| # | Holding | Type | Weight | Value | Shares / par | Country |
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly & Co. | Equity | 8.29% | $26M | 22,128 | |
| 2 | HUMHumana Inc. | Equity | 7.43% | $23M | 59,913 | |
| 3 | UTHRUnited Therapeutics Corp | Equity | 6.30% | $20M | 36,902 | |
| 4 | ARQTArcutis Biotherapeutics, Inc. Common Stock | Equity | 6.24% | $19M | 794,982 | |
| 5 | ABBVABBVIE INC. | Equity | 5.16% | $16M | 59,100 | |
| 6 | TMOThermo Fisher Scientific, Inc. | Equity | 4.64% | $14M | 22,216 | |
| 7 | WRBYWarby Parker Inc. | Equity | 4.61% | $14M | 576,964 | |
| 8 | JNJJohnson & Johnson | Equity | 4.51% | $14M | 54,832 | |
| 9 | UNHUNITEDHEALTH GROUP INCORPORATED (Delaware) | Equity | 4.48% | $14M | 37,684 | |
| 10 | AVTRAvantor, Inc. | Equity | 4.38% | $14M | 888,344 | |
| 11 | PCTPureCycle Technologies, Inc. Common stock | Equity | 3.85% | $12M | 3,059,049 | |
| 12 | JAZZJazz Pharmaceuticals, Inc. | Equity | 3.53% | $11M | 49,469 | |
| 13 | GILDGilead Sciences Inc | Equity | 3.51% | $11M | 74,565 | |
| 14 | DGXQuest Diagnostics Inc. | Equity | 3.37% | $11M | 45,565 | |
| 15 | BNTCBenitec Biopharma Inc. Common Stock | Equity | 3.07% | $9.6M | 1,095,355 | |
| 16 | SMMTSummit Therapeutics Inc. Common Stock | Equity | 2.58% | $8.1M | 469,129 | |
| 17 | AMGNAmgen Inc | Equity | 2.51% | $7.8M | 19,260 | |
| 18 | GHGuardant Health, Inc. Common Stock | Equity | 2.38% | $7.4M | 44,821 | |
| 19 | BHVNBiohaven Ltd. | Equity | 1.94% | $6.0M | 506,468 | |
| 20 | CAHCardinal Health, Inc. | Equity | 1.89% | $5.9M | 24,684 | |
| 21 | CVSCVS HEALTH CORPORATION | Equity | 1.79% | $5.6M | 63,756 | |
| 22 | GRALGRAIL, Inc. Common Stock | Equity | 1.68% | $5.2M | 39,518 | |
| 23 | TXG10x Genomics, Inc. Class A Common Stock | Equity | 1.55% | $4.8M | 62,758 | |
| 24 | VRTXVertex Pharmaceuticals Inc | Equity | 1.55% | $4.8M | 9,616 | |
| 25 | ESTAEstablishment Labs Holdings Inc. | Equity | 1.08% | $3.4M | 55,490 | |
| 26 | GEHCGE HealthCare Technologies Inc. Common Stock | Equity | 0.98% | $3.1M | 47,730 | |
| 27 | HSICHenry Schein Inc | Equity | 0.95% | $3.0M | 34,954 | |
| 28 | PCRXPacira BioSciences, Inc. Common Stock | Equity | 0.89% | $2.8M | 76,173 | |
| 29 | ELVElevance Health, Inc. | Equity | 0.85% | $2.7M | 6,651 | |
| 30 | Cash | Cash | 0.71% | $2.2M | 2,223,085 | |
| 31 | DHRDanaher Corporation | Equity | 0.61% | $1.9M | 8,751 | |
| 32 | EWEdwards Lifesciences Corp | Equity | 0.46% | $1.4M | 17,138 | |
| 33 | INSMInsmed, Inc. | Equity | 0.40% | $1.2M | 12,437 | |
| 34 | TGTXTG Therapeutics, Inc. | Equity | 0.33% | $1.0M | 19,529 | |
| 35 | COOThe Cooper Companies, Inc. Common Stock | Equity | 0.21% | $657K | 12,102 | |
| 36 | AGLagilon health, inc. | Equity | 0.21% | $656K | 7,739 | |
| 37 | SYKStryker Corporation | Equity | 0.18% | $573K | 2,070 | |
| 38 | FULCFulcrum Therapeutics, Inc. Common Stock | Equity | 0.17% | $529K | 140,994 | |
| 39 | NBIXNeurocrine Biosciences Inc | Equity | 0.14% | $430K | 3,045 | |
| 40 | ZBHZimmer Biomet Holdings, Inc. | Equity | 0.11% | $359K | 4,035 | |
| 41 | ABTAbbott Laboratories | Equity | 0.10% | $308K | 3,126 | |
| 42 | FLRFluor Corporation | Equity | 0.09% | $292K | 5,723 | |
| 43 | ICLRIcon Plc | Equity | 0.07% | $227K | 1,379 | |
| 44 | TFXTeleflex Incorporated | Equity | 0.05% | $168K | 1,349 | |
| 45 | SRPTSarepta Therapeutics,, Inc. Common Stock | Equity | 0.04% | $129K | 7,063 | |
| 46 | PRAXPraxis Precision Medicines, Inc. Common Stock | Equity | 0.03% | $90K | 342 | |
| 47 | VLTOVeralto Corporation | Equity | 0.02% | $68K | 708 | |
| 48 | BMYBristol-Myers Squibb Co. | Equity | 0.02% | $60K | 1,010 | |
| 49 | REGNRegeneron Pharmaceuticals Inc | Equity | 0.02% | $58K | 78 | |
| 50 | ABVXAbivax SA American Depositary Shares | Equity | 0.01% | $20K | 220 | |
| 51 | EMBCEmbecta Corp. Common Stock | Equity | 0.00% | $15K | 2,690 | |
| 52 | NVONovo-Nordisk A/S | Equity | 0.00% | $13K | 338 | |
| 53 | SNDXSyndax Pharmaceuticals, Inc. | Equity | 0.00% | $13K | 748 |
Find which other funds hold a stock by opening it and choosing "ETFs holding".
Position changes between reports
| Action | Holding | Weight before | Weight after | Shares vs flows | Between reports |
|---|---|---|---|---|---|
| Increase | UNHUNITEDHEALTH GROUP INC | 0.21% | 5.76% | +1971.8% | Mar 31, 2026 → Jun 30, 2026 SEC |
| Exit | Chugai Pharmaceutical Co Ltd. | 5.21% | — | — | Mar 31, 2026 → Jun 30, 2026 SEC |
| Decrease | ALGNALIGN TECHNOLOGY INC | 7.91% | 3.14% | −52.8% | Mar 31, 2026 → Jun 30, 2026 SEC |
| Decrease | REGNREGENERON PHARMACEUTICALS INC | 3.63% | 0.01% | −99.5% | Mar 31, 2026 → Jun 30, 2026 SEC |
| New position | DGXQUEST DIAGNOSTICS INC | — | 2.94% | — | Mar 31, 2026 → Jun 30, 2026 SEC |
| Increase | PCTPURECYCLE TECHNOLOGIES INC | 3.97% | 6.89% | +29.8% | Mar 31, 2026 → Jun 30, 2026 SEC |
| Increase | WRBYWARBY PARKER INC | 2.64% | 5.46% | +67.5% | Mar 31, 2026 → Jun 30, 2026 SEC |
| New position | ELVELEVANCE HEALTH INC | — | 2.73% | — | Mar 31, 2026 → Jun 30, 2026 SEC |
| Exit | MMM3M Company | 2.72% | — | — | Mar 31, 2026 → Jun 30, 2026 SEC |
| Increase | JNJJOHNSON & JOHNSON | 2.83% | 5.45% | +116.5% | Mar 31, 2026 → Jun 30, 2026 SEC |
| New position | CAHCARDINAL HEALTH INC | — | 1.78% | — | Mar 31, 2026 → Jun 30, 2026 SEC |
| Increase | NVONOVO NORDISK A/S | 5.19% | 6.75% | +16.4% | Mar 31, 2026 → Jun 30, 2026 SEC |
| Exit | ALHCAlignment Healthcare Inc | 1.45% | — | — | Mar 31, 2026 → Jun 30, 2026 SEC |
| Decrease | ISRGINTUITIVE SURGICAL INC | 2.14% | 0.83% | −47.5% | Mar 31, 2026 → Jun 30, 2026 SEC |
| Increase | BNTCBENITEC BIOPHARMA INC | 2.58% | 3.75% | +34.9% | Mar 31, 2026 → Jun 30, 2026 SEC |
| Decrease | BIOHAVEN LTD | 3.28% | 4.32% | −12.7% | Mar 31, 2026 → Jun 30, 2026 SEC |
| Exit | APLSApellis Pharmaceuticals Inc | 0.98% | — | — | Mar 31, 2026 → Jun 30, 2026 SEC |
| Decrease | LLYELI LILLY & COMPANY | 6.63% | 5.91% | −20.2% | Mar 31, 2026 → Jun 30, 2026 SEC |
| Decrease | ESTABLISHMENT LABS HOLDINGS INC | 1.30% | 1.45% | −13.9% | Mar 31, 2026 → Jun 30, 2026 SEC |
| Decrease | TXG10X GENOMICS INC | 3.23% | 3.13% | −37.4% | Mar 31, 2026 → Jun 30, 2026 SEC |
| Decrease | UNHUnitedHealth Group Inc. | 9.36% | 0.21% | −97.5% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Increase | UTHRUnited Therapeutics Corporation | 3.35% | 8.77% | +97.8% | Dec 31, 2025 → Mar 31, 2026 SEC |
| New position | Chugai Pharmaceutical Co Ltd. | — | 5.21% | — | Dec 31, 2025 → Mar 31, 2026 SEC |
| New position | NVONovo Nordisk A/S | — | 5.19% | — | Dec 31, 2025 → Mar 31, 2026 SEC |
| Decrease | REGNRegeneron Pharmaceuticals, Inc. | 7.44% | 3.63% | −55.2% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Increase | ALGNAlign Technology Inc. | 4.82% | 7.91% | +37.3% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Increase | ABBVAbbVie Inc. | 1.56% | 4.56% | +181.5% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Increase | TMOThermo Fisher Scientific Inc | 0.77% | 3.69% | +418.8% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Decrease | APLSApellis Pharmaceuticals Inc | 3.89% | 0.98% | −85.5% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Increase | MMM3M Company | 0.16% | 2.72% | +1650.2% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Decrease | AMGNAmgen Inc. | 4.93% | 2.41% | −58.3% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Increase | GILDGilead Sciences Inc. | 1.32% | 3.69% | +125.3% | Dec 31, 2025 → Mar 31, 2026 SEC |
| New position | AstraZeneca PLC | — | 2.20% | — | Dec 31, 2025 → Mar 31, 2026 SEC |
| Decrease | LLYEli Lilly & Co. | 8.66% | 6.63% | −17.8% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Increase | BNTCBenitec Biopharma Inc | 0.59% | 2.58% | +412.0% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Exit | AZNAstraZeneca PLC | 1.88% | — | — | Dec 31, 2025 → Mar 31, 2026 SEC |
| Increase | JNJJohnson & Johnson | 1.31% | 2.83% | +68.1% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Exit | PENPenumbra Inc | 1.39% | — | — | Dec 31, 2025 → Mar 31, 2026 SEC |
| Exit | MLYSMineralys Therapeutics Inc | 1.19% | — | — | Dec 31, 2025 → Mar 31, 2026 SEC |
| Exit | IQVIQVIA Holdings Inc | 1.13% | — | — | Dec 31, 2025 → Mar 31, 2026 SEC |
| Decrease | INSMInsmed Inc | 1.77% | 0.72% | −60.2% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Exit | OSCROscar Health Inc | 0.85% | — | — | Dec 31, 2025 → Mar 31, 2026 SEC |
| Increase | PCTPURECYCLE TECHNOLOGIES INC | 4.78% | 3.97% | +26.1% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Decrease | VRTXVertex Pharmaceuticals Incorporated | 2.28% | 1.53% | −37.6% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Exit | ARGXArgenx SE | 0.75% | — | — | Dec 31, 2025 → Mar 31, 2026 SEC |
| Decrease | HQYHealthequity Inc | 0.72% | 0.01% | −98.4% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Decrease | ABVXAbivax SA | 0.66% | 0.01% | −98.2% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Decrease | CYPHCypherpunk Technologies Inc. | 0.63% | 0.01% | −98.5% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Decrease | SNDXSyndax Pharmaceuticals Inc. | 0.33% | 0.01% | −98.4% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Exit | CICigna Group/The | 0.27% | — | — | Dec 31, 2025 → Mar 31, 2026 SEC |
| Increase | Biohaven Ltd | 3.12% | 3.28% | +29.1% | Dec 31, 2025 → Mar 31, 2026 SEC |
| Exit | CHWYChewy Inc | 0.13% | — | — | Dec 31, 2025 → Mar 31, 2026 SEC |
Share-count changes are measured after removing what creations and redemptions explain.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.